BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30282673)

  • 21. Hemostatic Effects of Tranexamic Acid in Cesarean Delivery: An Ancillary Study of the TRAAP2 Study.
    Roullet S; Rivoire T; Houssin C; Labrouche S; Paquin S; Nouette-Gaulain K; Deneux-Tharaux C; Amiral J; James C; Sentilhes L
    Thromb Haemost; 2022 Nov; 122(11):1869-1878. PubMed ID: 36075235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
    Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
    Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
    Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
    Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis.
    Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T
    Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of Fibrinolysis Using Velocity Curves Measured with Thromboelastometry in Children with Congenital Heart Disease.
    Faraoni D; Van der Linden P; Ducloy-Bouthors AS; Goobie SM; DiNardo JA; Nielsen VG
    Anesth Analg; 2015 Aug; 121(2):486-91. PubMed ID: 26049780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectively.
    Bareille M; Lecompte T; Mullier F
    Thromb Res; 2023 Oct; 230():33-36. PubMed ID: 37633059
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and application of global assays of hyper- and hypofibrinolysis.
    Ilich A; Noubouossie DF; Henderson M; Ellsworth P; Betbadal KF; Campello E; Meeks S; Dunn A; Park MS; Pawlinski R; Simioni P; Shapiro A; Key NS
    Res Pract Thromb Haemost; 2020 Jan; 4(1):46-53. PubMed ID: 31989084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.
    Bønløkke ST; Fenger-Eriksen C; Ommen HB; Hvas AM
    Blood Adv; 2023 Nov; 7(22):7056-7066. PubMed ID: 37756519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
    Leaker MT; Brooker LA; Mitchell LG; Weitz JI; Superina R; Andrew ME
    Transplantation; 1995 Jul; 60(2):144-7. PubMed ID: 7624956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.
    Urano T; Sumiyoshi K; Pietraszek MH; Takada Y; Takada A
    Thromb Haemost; 1991 Oct; 66(4):474-8. PubMed ID: 1796399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring fibrinolysis in whole blood by viscoelastic instruments: a comparison of ROTEM and ReoRox.
    Nilsson CU; Tynngård N; Reinstrup P; Engström M
    Scand J Clin Lab Invest; 2013 Sep; 73(6):457-65. PubMed ID: 23767889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ROTEM diagnostic capacity for measuring fibrinolysis in neonatal sepsis.
    Lampridou M; Sokou R; Tsantes AG; Theodoraki M; Konstantinidi A; Ioakeimidis G; Bonovas S; Politou M; Valsami S; Iliodromiti Z; Boutsikou T; Iacovidou N; Nikolopoulos G; Tsantes AE
    Thromb Res; 2020 Aug; 192():103-108. PubMed ID: 32464452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
    Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of fibrinolytic status in whole blood using a dielectric coagulometry microsensor.
    Pourang S; Sekhon UDS; Disharoon D; Ahuja SP; Suster MA; Sen Gupta A; Mohseni P
    Biosens Bioelectron; 2022 Aug; 210():114299. PubMed ID: 35533507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Fibrinolysis Assays Reveal Different Mechanisms underlying Plasminogen Dysfunction in Ligneous Conjunctivitis.
    Bourrienne MC; Loyau S; Faille D; de Raucourt E; de Mazancourt P; Ho-Tin-Noé B; Gabison E; Ajzenberg N
    Thromb Haemost; 2020 May; 120(5):758-767. PubMed ID: 32369847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig.
    Bakker CM; Blankensteijn JD; Schlejen P; Porte RJ; Gomes MJ; Lampe HI; Stibbe J; Terpstra OT
    HPB Surg; 1994; 7(4):265-80. PubMed ID: 8204546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.